REED JOHN C — SEC Form 4 filings
SEC reporting owner CIK 1181561. 11 Form 4 filings on record with FilingPulse; latest filed 2026-08-18.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-02-20 to 2026-08-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 3 filings — 94,789 shares, $20,420,856 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 35.
- Largest priced transaction: sale of 29,927 shares @ $243.00 ($7,272,261) in JOHNSON & JOHNSON, filed 2026-02-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| JOHNSON & JOHNSON (JNJ) | EVP, Innovative Medicine, R&D | 10 | — | 5 legs · 94,789 sh · $20,420,856 | 33 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Director | 1 | — | — | 2 |
Form 4 filings — REED JOHN C
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-18 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/award (A): 647 @ $0 · Grant/award (A): 1,078 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | JOHNSON & JOHNSON (JNJ) | Option exercise (M): 25,255 @ $0 · Tax withholding (F): 11,002 @ $229.85 · Option exercise (M): 25,255 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | JOHNSON & JOHNSON (JNJ) | Option exercise (M): 1,349 @ $0 · Tax withholding (F): 385 @ $243.45 · Option exercise (M): 1,847 @ $0 · Tax withholding (F): 528 @ $243.45 · Option exercise (M): 21,721 @ $157.92 · Sale (S): 21,721 @ $243 · +9 more | EDGAR |
| 2025-10-20 | 4 | JOHNSON & JOHNSON (JNJ) | Option exercise (M): 21,721 @ $157.92 · Sale (S): 21,721 @ $192.71 · Option exercise (M): 21,721 (derivative) @ $157.92 | EDGAR |
| 2025-07-18 | 4 | JOHNSON & JOHNSON (JNJ) | Sale (S): 19,137 @ $163.55 | EDGAR |
| 2025-05-05 | 4 | JOHNSON & JOHNSON (JNJ) | Option exercise (M): 25,255 @ $0 · Tax withholding (F): 11,002 @ $156.31 · Option exercise (M): 25,255 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | JOHNSON & JOHNSON (JNJ) | Grant/award (A): 89,781 (derivative) @ $0 · Grant/award (A): 5,539 (derivative) @ $0 | EDGAR |
| 2025-02-18 | 4 | JOHNSON & JOHNSON (JNJ) | Option exercise (M): 1,350 @ $0 · Tax withholding (F): 385 @ $156.15 · Option exercise (M): 1,350 (derivative) @ $0 | EDGAR |
| 2024-10-31 | 4/A | JOHNSON & JOHNSON (JNJ) | Option exercise (M): 25,255 @ $0 · Tax withholding (F): 10,984 @ $144.59 · Option exercise (M): 25,255 (derivative) @ $0 | EDGAR |
| 2024-05-03 | 4 | JOHNSON & JOHNSON (JNJ) | Option exercise (M): 22,255 @ $0 · Tax withholding (F): 10,984 @ $144.59 · Option exercise (M): 22,255 (derivative) @ $0 | EDGAR |
| 2024-02-20 | 4 | JOHNSON & JOHNSON (JNJ) | Grant/award (A): 65,163 (derivative) @ $0 · Grant/award (A): 4,048 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1181561 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →